27 states, DC, sue 23andMe over sale of DNA data, NY Times reports

Genetic testing company 23andMe (ME) is being sued by 27 states and Washington, DC to oppose the sale of DNA data from its customers without their direct consent, The New York Times’ Rylee Kirk reports. The suit, filed on Monday in U.S. Bankruptcy Court in the Eastern District of Missouri, argues that 23andMe needs to have permission from each and every customer before their data is potentially sold and that the information for sale “comprises an unprecedented compilation of highly sensitive and immutable personal data of consumers.” 23andMe filed for bankruptcy in March, and is poised to be acquired by Regeneron Pharmaceuticals (REGN) for $256M, the lawsuit notes.